NCT00737412View on ClinicalTrials.gov

Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

277

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

January 31, 2010

Conditions
Diarrhea
Interventions
OTHER

Probiotic: Bio-K+ CL1285

The probiotic Bio-K+ CL1285 RX®, a mixture of Lactobacillus acidophilus and Lactobacillus casei, contains over 50 billion living bacteria per administered dose.

OTHER

Placebo

Matching capsules devoid of microorganisms

Trial Locations (4)

J6E 1G2

Clinique Santé Voyage des Prairies, Joliette

H7G2E6

Clinique Santé Voyage de Laval, Laval

H2X 2H9

Clinique Santé Voyage Saint-Luc, Montreal

H3A 3C6

Sant Voyage Medisys, Montreal

Sponsors
All Listed Sponsors
collaborator

ethica Clinical Research Inc.

INDUSTRY

lead

Bio-K Plus International Inc.

INDUSTRY

NCT00737412 - Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults | Biotech Hunter | Biotech Hunter